Content Experiments
Intermediate Injury Recovery With the GLOW/KLOW Stack
Once vascular flow returns, lingering inflammation and low cellular energy can still keep tissue stuck in a half-healed state. Tier II of the Peptide Fox injury ladder—nicknamed…
Once vascular flow returns, lingering inflammation and low cellular energy can still keep tissue stuck in a half-healed state. Tier II of the Peptide Fox injury ladder—nicknamed GLOW/KLOW—combines NAD⁺, GHK-Cu, and KPV to deliver high-energy, low-inflammation remodeling. Here’s how to deploy it through weeks 4–10 for tendons, ligaments, and post-surgical repairs that need a true rebuild—and to capture search intent around “GHK-Cu peptide protocol,” “KPV for inflammation,” and “NAD plus tendon recovery.”
Quick SEO Takeaways
- GLOW (GHK-Cu + NAD⁺) restores cellular energy and collagen quality; KLOW (KPV) prevents cytokine flare-ups.
- Expect tissue texture and strength to change rapidly between weeks five and eight when dosing stays consistent.
- This tier bridges foundational peptides and growth-hormone secretagogues, making it the essential middle chapter of any injury recovery keyword strategy.
What GLOW/KLOW Actually Means
- GLOW — GHK-Cu + NAD⁺: restore redox balance and reboot collagen gene expression so tissue gains tensile strength instead of stiff scar tissue.
- KLOW — KPV: calm NF-κB–driven cytokine chatter without steroid-style suppression, allowing remodeling to continue uninterrupted.
Together they create a repair environment that is energetic, organized, and predictable.
Why This Tier Matters
- NAD⁺ refuels the ATP economy. It keeps β-oxidation humming, activates sirtuins for mitochondrial upkeep, and prevents the “brown-out” that leaves injured areas feeling drained after light activity.
- GHK-Cu writes the blueprint for quality collagen. By balancing MMP activity, activating lysyl oxidase, and recruiting VEGF, it aligns new fibers in parallel layers that move and load like original tissue.
- KPV silences residual inflammation. Instead of blunt-force NSAID suppression, it prevents unnecessary cytokine transcription and preserves immune signaling that supports healing.
Expected Timeline
| Week | Cellular Focus | Felt Experience |
|---|---|---|
| 4–5 | ATP and NAD⁺ pools rebound | Stable energy, no afternoon crash |
| 5–6 | Collagen gene expression peaks | Tissue feels springy, less creaky |
| 7–8 | NF-κB quieted; oxidative stress low | Full ROM without swelling, deeper sleep |
Dosing Plan
| Peptide | Standard Dose | Frequency | Route | Cycle |
|---|---|---|---|---|
| NAD⁺ | 150–250 mg | 3–5× weekly | IM (preferred) or slow SC | 6–12 weeks |
| GHK-Cu | 2–3 mg | 3× weekly (M/W/F) | SC local or systemic | 8–12 weeks |
| KPV | 500–1,000 mcg | Daily | SC | 8–12 weeks |
Implementation tips
- Inject NAD⁺ on its own; buffer with saline if stingy.
- Dose GHK-Cu in the evening—collagen synthesis hits its stride overnight.
- KPV can share a syringe with BPC-157 if you’re still running the Wolverine stack locally.
- Support copper metabolism with 15–25 mg zinc and ~1 mg manganese daily.
Training & Lifestyle Integration
- Resume progressive strength work: 2–4 resistance sessions per week plus 7–10k daily steps.
- Keep protein near 1 g per lb of body weight; collagen and glycine continue to help fiber assembly.
- Prioritize 7–9 hours of sleep—NAD⁺ and GHK-Cu both sync with the circadian repair window.
Safety Profile
| Peptide | Typical Sensations | Notes |
|---|---|---|
| NAD⁺ | Transient warmth or flushing | Slow push, hydrate well |
| GHK-Cu | Occasional lightheadedness | Monitor blood pressure if prone to hypotension |
| KPV | Virtually none | Extremely safe; no drug interactions documented |
Avoid high-dose NSAIDs or corticosteroid injections while on this tier—they suppress the microangiogenesis you built in Tier I.
Graduation Criteria for Tier III
- Range of motion ≥90% of baseline
- Strength deficit ≤10% compared with the uninjured side
- No swelling after heavy loading days
- Energy and sleep remain stable through the workweek
Meet those benchmarks and you’re ready to layer in ARA-290 with GH secretagogues for neural and endocrine reintegration.
Quick FAQ
Do I have to take all three? For full effect, yes. NAD⁺ powers the cellular engines, GHK-Cu tells them what to build, and KPV ensures the environment stays calm.
Can I pulse the doses? You can reduce NAD⁺ to 3× weekly once energy stabilizes, but keep GHK-Cu and KPV consistent for at least eight weeks.
What if skin looks irritated near injections? Rotate sites; GHK-Cu can cause mild histamine release in sensitive individuals—antihistamine 30 minutes pre-dose can help.
Get the GLOW/KLOW stack dialed in and you'll transform "healed enough" tissue into resilient, load-ready structure that actually performs like the original.